Apposite Capital
Growth equityLondon · Growth–Late Stage · 22 people tracked
Find your way into Apposite Capital
2,178 people in our graph share verified history with the Apposite Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Apposite Capital targets healthcare and life sciences SMEs across the UK and Europe, acting as first institutional capital to help them scale via growth and hybrid capital, management buyouts and buy-ins, retirement sales and founder transitions. It leverages deep sector expertise and a network of healthcare leaders to identify high-growth, high-impact opportunities. Its mission centers on enabling better healthcare for more people through three impact objectives: improving quality, increasing access, and promoting innovation. Value creation focuses on professionalising operations, recruiting talent, digital transformation, strengthening governance, and supporting buy-and-build strategies.
Source: firm website, verified Aug 3, 2026.
Team · 22 people
from the firm's website & curatedWhat they invest in
from 8 of 24 portfolio companiesHealthtech ×7Wellness & Fitness ×5Digital Health ×4Medical Devices ×4Mental Health ×2AI & Machine Learning ×1Cloud Computing ×1Consumer ×1
HQs:United Kingdom×3Sweden×1United States×1
Investments · 24 tracked
founders shown can be your intro pathBy year:2025 · 12022 · 23 dated
Cloudflare provides a global cloud network platform delivering security, performance, and development services through sixty-plus integrated services including SASE, application security, and full-stack development infrastructure.
Cloud ComputingCybersecurityDeveloper ToolsSan Francisco, US
Matthew Prince(Founder)inDane Knechtin
Co-investorsCapitalGEQT VenturesFlagship PioneeringIcon VenturesKhosla VenturesLocalGlobe+14 more
HCML provides occupational health, case management, and rehabilitation services to support workforce health and complex injury recovery.
Digital HealthEnterprise SoftwareHealthtechHR TechWellness & Fitness
James Murray(CEO)inJill Pritchard(Commercial and Healthcare Leader)inVish Buldawoo(Chief Operating Officer)inMarc Holl(Clinical Services Leader)inRory Webster(Chief Financial Officer)in
Pharmaceuticals & life sciences business (MBI)
Co-investorsKartesia
Lansen Omsorg operates LSS group homes (gruppbostäder) providing supported housing, a personal living coach, daily activities, and around-the-clock staffing for adults aged 18 and older with Asperger's, autism, autism-like conditions, or intellectual disabilities, including those with additional psychiatric needs.
HealthtechMental HealthWellness & Fitness
Mirada develops medical imaging software solutions that personalize image-guided cancer treatment to improve patient outcomes.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Dr Karen Fitchett(Chief Executive Officer)
Riverdale Healthcare is a dental healthcare provider offering oral surgery and related dental services including tooth removal, implants, and sedation procedures.
Digital HealthHealthtechMedical DevicesWellness & FitnessEngland, GB
Hassan
Swanton Care is a health and social care provider in the UK that delivers person-centered care services.
Digital HealthHealthtechMental HealthWellness & Fitness
Ultherapy develops FDA-cleared ultrasound devices that use microfocused ultrasound and real-time imaging to lift skin and stimulate collagen production without surgery.
ConsumerHealthtechMedical DevicesWellness & Fitness
Co-investorsNew Enterprise Associates (NEA)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
1MEDBy the BridgeCancerPartnersUKCrestOpticsHabitusi2aImaging HoldingsMC Care HoldingsNIMGeneticsOctavia House SchoolsSkip to main contentSummit MedicalSureCalmWellPartnerZonare
Exits · 1
1 acquisitionsZonareacq. by Mindray
Portfolio news
latest coverage across their companiesCloudflare Turnstile · marketbeat.com · Jul 18, 2026
Swanton Care · frpadvisory.com · Jan 22, 2026
Kelso Pharma · insidermedia.com · Mar 27, 2025
Principals & officers · per Companies House
what is this? ⓘLLP designated member · since 2015
LLP designated member · since 2006
LLP member · since 2017
Rory Christian Robert Pope — significant influence or control limited liability partnership
Ford David Porter — 25–50% of voting rights, right to share surplus assets 25 to 50 percent limited liability partnership
Samuel James Caiger Gray — 25–50% of voting rights, right to share surplus assets 25 to 50 percent limited liability partnership
Frequently asked questions
- How many investments has Apposite Capital made?
- Apposite Capital has 24 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Apposite Capital invest at?
- Apposite Capital invests at the Growth, Late Stage stages.
- What sectors does Apposite Capital focus on?
- Apposite Capital focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Apposite Capital located?
- Apposite Capital is headquartered in London, GB.
- Does Apposite Capital lead rounds?
- Yes, Apposite Capital leads investment rounds.
- Who does Apposite Capital co-invest with?
- Apposite Capital most often shares deals with New Enterprise Associates (NEA), EQT Ventures, Flagship Pioneering, among 22 tracked co-investors.
Images
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Visionary Ventures is a venture capital fund investing from Series A through commercialization, leveraging partnerships with Key Opinion Leaders, industry experts, and strategic acquirers to source and vet deals.
Claret Capital Partners is a European venture debt provider that finances technology, life sciences and impact companies, having deployed over €1.5bn across more than 200 companies.






































